- Home
- SAVA vs ORLA Comparison
SAVA vs ORLA Comparison
Compare SAVA & ORLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAVA
- ORLA
- Stock Information
- Founded
- SAVA 1998
- ORLA 2007
- Country
- SAVA United States
- ORLA Canada
- Employees
- SAVA N/A
- ORLA N/A
- Industry
- SAVA Biotechnology: Pharmaceutical Preparations
- ORLA Precious Metals
- Sector
- SAVA Health Care
- ORLA Basic Materials
- Exchange
- SAVA Nasdaq
- ORLA Nasdaq
- Market Cap
- SAVA 1.3B
- ORLA 1.3B
- IPO Year
- SAVA N/A
- ORLA N/A
- Fundamental
- Price
- SAVA $26.91
- ORLA $3.96
- Analyst Decision
- SAVA Strong Buy
- ORLA Buy
- Analyst Count
- SAVA 3
- ORLA 2
- Target Price
- SAVA $111.50
- ORLA $6.13
- AVG Volume (30 Days)
- SAVA 1.3M
- ORLA 535.6K
- Earning Date
- SAVA 11-07-2024
- ORLA 11-12-2024
- Dividend Yield
- SAVA N/A
- ORLA N/A
- EPS Growth
- SAVA N/A
- ORLA N/A
- EPS
- SAVA N/A
- ORLA 0.01
- Revenue
- SAVA N/A
- ORLA $314,101,000.00
- Revenue This Year
- SAVA N/A
- ORLA $35.64
- Revenue Next Year
- SAVA N/A
- ORLA $0.41
- P/E Ratio
- SAVA N/A
- ORLA $284.77
- Revenue Growth
- SAVA N/A
- ORLA 38.09
- 52 Week Low
- SAVA $8.79
- ORLA $2.60
- 52 Week High
- SAVA $42.20
- ORLA $5.17
- Technical
- Relative Strength Index (RSI)
- SAVA 51.05
- ORLA 33.77
- Support Level
- SAVA $25.00
- ORLA $3.81
- Resistance Level
- SAVA $28.18
- ORLA $4.72
- Average True Range (ATR)
- SAVA 1.81
- ORLA 0.20
- MACD
- SAVA 0.07
- ORLA -0.13
- Stochastic Oscillator
- SAVA 62.39
- ORLA 12.16
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.
About ORLA Orla Mining Ltd.
Orla Mining Ltd is a mineral exploration company. It is engaged in the acquisition and exploration of mineral properties. The company holds three gold projects; the Camino Rojo gold and silver project in Zacatecas State, Mexico, and the South Railroad and Lewis gold projects in Nevada, USA, and the Cerro Quema gold project in Panama. It conducts business activities in Mexico, Panama, the United States, and Canada.